Weight gain in perimenopausal women: methods for assessing the body composition and maintenance tactics


Citar

Texto integral

Acesso aberto Acesso aberto
Acesso é fechado Acesso está concedido
Acesso é fechado Acesso é pago ou somente para assinantes

Resumo

Perimenopausal women show weight gain and a tendency for central fat distribution, which results in metabolic disorders that contribute to the development of diabetes and cardiovascular disease (CVD). Taking into consideration that the latter is the main cause of death in postmenopausal women, the importance of controlling body weight and the presence of visceral obesity just in menopause cannot be overestimated. For this, the anthropometric methods to assess adipose tissue distribution, which are characterized by their ease of use and widespread availability, can be used. The menopausal transition is a critical period when the use of optimal diagnostic and therapeutic approaches can prevent a number of undesirable consequences of changes in the hormonal profile. A healthy lifestyle (adequate physical activity, diet), as well as the use of combined oral contraceptives containing estradiol can inhibit the development of adverse changes in body composition and improve quality of life in perimenopausal women.

Texto integral

Acesso é fechado

Sobre autores

Svetlana Yureneva

Academician V.I. Kulakov National Medical Research Center of Obstetrics, Gynecology, and Perinatology, Ministry of Health of Russia

Email: syureneva@gmail.com
PhD, MD, Professor of Department of Obstetrics and Gynecology of the Department of Vocational Education

Veronika Komedina

Academician V.I. Kulakov National Medical Research Center of Obstetrics, Gynecology, and Perinatology, Ministry of Health of Russia

Email: komedina.veronika@gmail.com
Ph.D. student of gynecological endocrinology department

Sergey Kuznetsov

Academician V.I. Kulakov National Medical Research Center of Obstetrics, Gynecology, and Perinatology, Ministry of Health of Russia

Ph.D., obstetrician-gynecologist, radiologist, gynecological endocrinology department

Bibliografia

  1. Прилепская В.Н. Климактерический синдром: инновации в менопаузальной терапии. РМЖ. Мать и дитя. 2017; 25(2): 105-8.
  2. Harlow S.D., Gass M., Hall J.E., Lobo R., Maki P., Rebar R.W. et al. Executive Summary of the States of Reproductive Aging Workshop +10: addressing the unfinished agenda of staging reproductive aging. Menopause. 2012; 19(4): 38795. https://dx.doi.org/10.1097/gme.0b013e31824d8f40.
  3. Продовольственная и сельскохозяйственная организация Объединенных Наций. Римская декларация по вопросам питания. ВОЗ; 2014. [Food and Agriculture Organization of the United Nations. The Rome Declaration on Nutrition. WHO; 2014]. Available at: http://www.fao.org/3Za-ml542r.pdf
  4. Williams E.P., Mesidor M., Winters K., Dubbert P.M., Wyatt S.B. Overweight and obesity: prevalence, consequences, and causes of a growing public health problem. Curr. Obes. Rep. 2015; 4(3): 363-70. https://dx.doi.org/10.1007/ s13679-015-0169-4.
  5. Green dale G.A., Sternfeld B., Mei Hua Huang, Weijuan Han, Karvonen-Gutierrez C., Ruppert K. et al. Changes in body composition and weight during the menopause transition. JCI Insight. 2019; 4(5): e124865. https://dx.doi. org/10.1172/jci.insight.124865.
  6. Varsha Singh, Meena Sahu, Somnath Yadav, Harris K.K. Incidence of obesity among the pre-menopausal and post-menopausal working women of Raipur district (Chhattisgarh State). World J. Sci. Technol. 2012; 2(6): 83-6.
  7. Kapoor E., Collazo-Clavell M.L., Stephanie S. Faubion S.S. Weight gain in women at midlife: a concise review of the pathophysiology and strategies for management. Mayo Clin. Proc. 2017; 92(10): 1552-8. https://dx.doi. org/10.1016/j.mayocp.2017.08.004.
  8. Davis S.R., Castelo-Branco C., Chedraui P., Lumsden M.A., Nappi R.E., Shah D., Villaseca P. Understanding weight gain at menopause. Climacteric. 2012; 15(5): 419-29. https://dx.doi.org/10.3109/13697137.2012.707385.
  9. Karvonen-Gutierrez C., Kim C. Association of mid-life changes in body size, body composition and obesity status with the menopausal transition. Healthcare (Basel). 2016; 4(3): 42. https://dx.doi.org/10.3390/healthcare4030042.
  10. Протасова А.Э., Юренева С.В., Байрамова Н.Н., Комедина В.И. Менопауза, ожирение и коморбидность: возможности менопаузальной гормональной терапии. Акушерство и гинекология. 2019; 5: 43-8. https://dx.doi.org/10.18565/aig.2019.5.43-48
  11. Liu X.M., Chan H.C., Ding G.L., Cai J., Song Y., Wang T.T. et al. FSH regulates fat accumulation and redistribution in aging through the Gai/Ca2+/ CREB pathway. Aging Cell. 2015; 14: 409-20. 10.1111/acel.12331.
  12. Liu P., Yaoting Ji, Yuen T., Rendina-Ruedy E., DeMambro V.E., Samarth Dhawan. Blocking FSH induces thermogenic adipose tissue and reduces body fat. Nature. 2017; 546(7656): 107-12. https://dx.doi.org/10.1038/nature22342.
  13. Tchernof A., Despres J.P. Pathophysiology of human visceral obesity: an update. Physiol. Rev. 2013; 93(1): 359-404. https://dx.doi.org/10.1152/ physrev.00033.2011.
  14. Романцова Т.И., Островская Е.В. Метаболически здоровое ожирение: дефиниции, протективные факторы, клиническая значимость. Альманах клинической медицины. 2015; Спецвыпуск 1: 75-86. [Romantsova T.I., Ostrovskaya E.V. Metabolically healthy obesity: definitions, protective factors, clinical relevance. Almanac ofClinical Medicine/Al'manah kliniceskoj mediciny. 2015; Suppl. 1: 75-86. (in Russian)]. https://dx.doi.org/10.18786/2072-0505-2015-1-75-86.
  15. Camhi S.M., Katzmarzyk P.T. Differences in body composition between metabolically healthy obese and metabolically abnormal obese adults. Int. J. Obes. 2014; 38(8): 1142-5. https://dx.doi.org/10.1038/ijo.2013.208.
  16. Banack H.R., Wactawski-Wende J., Hovey K., Stokes A. Is BMI a valid measure of obesity in postmenopausal women? Menopause. 2018; 25(3): 307-13. https:// dx.doi.org/10.1097/GME.0000000000000989.
  17. D/Berker, Suha Koparal, Serhat I§ik, Lale Pa§aoglu, Yusuf Aydin, Kutlu Erol. et al. Compatibility of different methods for the measurement of visceral fat in different body mass index strata. Diagn Interv Radiol. 2010; 16(2): 99-105. https://dx.doi.org/10.4261/1305-3825.DIR.2749-09.1.
  18. Corbatorn Anchuelo A., Martirnez-Larrad M.T., Serrano-Garcira I., Fernarndez Perrez C., Serrano-Riros M. Body fat anthropometric indexes: Which of those identify better high cardiovascular risk subjects? A comparative study in Spanish population. PLoS One. 2019; 14(5): e0216877. https://dx.doi.org/10.1371/ journal.pone.0216877.
  19. Roriz A.K., Passos L.C., de Oliveira C.C., Eickemberg M., Moreira P.deA., Sampaio L.R. Evaluation of the accuracy of anthropometric clinical indicators of visceral fat in adults and elderly. PLoS One. 2014; 9(7): e103499. https://dx.doi. org/10.1371/journal.pone.0103499.
  20. Swainson M.G., Batterham A.M., Tsakirides C., Rutherford Z.H., Hind K. Prediction of whole-body fat percentage and visceral adipose tissue mass from five anthropometric variables. PLoS One. 2017; 12(5): e0177175. https://dx.doi. org/10.1371/journal.pone.0177175.
  21. Zhao L., Huang G., Xia F., Li Q., Han B., Chen Y. et al. Neck circumference as an independent indicator of visceral obesity in a Chinese population. Lipids Health Dis. 2018; 17(1): 85. https://dx.doi.org/10.1186/ s12944-018-0739-z.
  22. Kaul S., Rothney M., Peters D., Wacker W.K., Davis C.E., Shapiro M.D., Ergun D.L. Dual-energy X-ray absorptiometry for quantification of visceral fat. Obesity (Silver Spring). 2012; 20(6): 1313-8. https://dx.doi.org/10.1038/ oby.2011.393.
  23. Day K., Kwok A., Evans A., Mata F., Verdejo-Garcia A., Hart K. et al. Comparison of a bioelectrical impedance device against the reference method dual energy X-ray absorptiometry and anthropometry for the evaluation of body composition in adults. Nutrients. 2018; 10(10). pii: E1469. https://dx.doi.org/10.3390/ nu10101469.
  24. Brown H.L., Warner J.J., Gianos E., Gulati M., Hill A.J., Hollier L.M. et al. Promoting risk identification and reduction of cardiovascular disease in women through collaboration with obstetricians and gynecologists: A Presidential Advisory From the American Heart Association and the Am erican College of Obstetricians and Gynecologists. Circulation. 2018; 137(24): e843-52. https://dx.doi.org/10.1161/CIR.0000000000000582.
  25. Jensen M.D., Ryan D.H., Apovian C.M., Ard J.D., Comuzzie A.G., Donato K.A. et al. 2013 AHA/ACC/TOS guideline for the management of overweight and obesity in adults: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines and the Obesity Society. J. Am. Coll. Cardiol. 2014; 63(25,PtB): 2985-3023. https://dx.doi.org/10.1016/j. jacc.2013.11.004. Erratum in J. Am. Coll. Cardiol. 2014; 63(25, Pt B): 3029-30.
  26. Alamuddin N., Bakizada Z., Wad den T.A. Management of obesity. J. Clin. Oncol. 2016; 34(35): 4295-305. https://dx.doi.org/10.1200/ JCO.2016.66.8806.
  27. Прилепская В.Н., ред. Руководство по контрацепции. 5-е изд. М.: МЕДпресс-информ; 2018: 274-8
  28. Shifren J.L., Gass M.L.; NAMS Recommendations for Clinical Care of Midlife Women Working Group. The North American Menopause Society recommendations for clinical care of midlife women. Menopause. 2014; 21(10): 1038-62. https://dx.doi.org/10.1097/GME.0000000000000319.
  29. American Society for Reproductive Medicine. The menopausal transition (perimenopause): what is it? American Society for Reproductive Medicine; 2015. Available at: https://www.reproductivefacts.org/globalassets/rf/news-and-publications/bookletsfact-sheets/english-factsheets-and-info-booklets/ menopause_transition_perimenopause_what_is_it_ factsheet.pdf.
  30. Miller T.A., Allen R.H., Kaunitz A.M., Cwiak C.A. Contraception for midlife women: a review. Menopause. 2018; 25(7): 817-27. https://dx.doi.org/10.1097/ GME.0000000000001073.
  31. Paoletti A.M., Lello S., Di Carlo C., Orru M., Malune M.E., Neri M. et al. Effect of Estradiol valerate plus dienogest on body composition of healthy women in the menopausal transition: a prospective one-year evaluation. Gynecol. Endocrinol. 2016; 32(1): 61-4. https://dx.doi.org/10.3109/ 09513590.2015.1079175.
  32. Moon Kyoung Cho. Use of Combined Oral Contraceptives in Perimenopausal Women. Chonnam Med J. 2018; 54: 153-8. https://doi.org/10.4068/ cmj.2018.54.3.153

Arquivos suplementares

Arquivos suplementares
Ação
1. JATS XML

Declaração de direitos autorais © Bionika Media, 2020

Este site utiliza cookies

Ao continuar usando nosso site, você concorda com o procedimento de cookies que mantêm o site funcionando normalmente.

Informação sobre cookies